B&K CORPORATION LIMITED
华芢生物科技（青岛）股份有限公司
02396.HK
China-based biopharmaceutical company developing protein drugs for wound healing, focusing on PDGF therapies for burns and diabetic foot ulcers. Its pipeline includes two core products in clinical trials and eight other candidates.
Biotech & PharmaChapter 18ASponsorsHuatai · CITIC SecuritiesCounselClifford Chance
Filings
The documents are on HKEXnews; we link to the originals.
| 2025-12-12 | Prospectus | HKEXnews |
Matters the filing discloses
From the company’s latest filing; open a kind of matter to see how other companies disclosed it.